Naltrexone Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers, 9 USDMF, 7 CEP/COS, 3 EU WC, 6 KDMF, 32 NDC API, 18 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

45 Dossiers, 23 FDA Orange Book, 12 Europe, 4 Canada, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 35 Kerry, 18 Corel Pharma Chem, 17 BASF, 12 Seppic, 11 Microlex e.U, 11 Sigachi Industries, 10 Gangwal Chemicals, 10 Roquette, 9 Ideal Cures Pvt Ltd, 8 Gangwal Healthcare, 8 Actylis, 6 Lonza Capsugel, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 DFE Pharma, 4 Nanjing Well Pharmaceutical, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 ACG Worldwide, 4 Kima Chemical, 3 Vasa Pharmachem, 3 DKSH, 3 The Dow Chemical Company, 3 Prachin Chemical, 2 Jai Radhe Sales, 2 Evonik, 2 Qualicaps, 2 Nomisma Healthcare, 2 Seqens, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Alcedo Pharmachem, 1 Clariant, 1 Ingredion Pharma Solutions, 1 Nanjing Bold Chemical, 1 Pfanstiehl, 1 Pharmatrans-Sanaq, 1 Vertellus, 1 SPI Pharma, 1 Aeon Procare, 1 Finar

EXCIPIENTS BY APPLICATIONS

60 Coating Systems & Additives, 49 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 22 Direct Compression, 19 Solubilizers, 19 Thickeners and Stabilizers, 18 Granulation, 17 Disintegrants & Superdisintegrants, 14 Lubricants & Glidants, 13 Parenteral, 13 Topical, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 11 Taste Masking, 9 Empty Capsules, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 15 Finished Drug Prices

MARKET PLACE

14 APIs, 3 DOSSIERS // FDF

PATENTS

86 US Patents

86 US Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 7 Other Ref. Standards

DIGITAL CONTENT

47 News

47 News

Drug Approvals by the Medicines Control Council in South Africa containing Naltrexone Hydrochloride. Original Data : South African Medicines Price Registry

Naltrexone Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers

9 USDMF

7 CEP/COS

3 EU WC

6 KDMF

32 NDC API

18 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

45 Dossiers

23 FDA Orange Book

12 Europe

4 Canada

2 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

35 Kerry

18 Corel Pharma Chem

17 BASF

12 Seppic

11 Microlex e.U

11 Sigachi Industries

10 Gangwal Chemicals

10 Roquette

9 Ideal Cures Pvt Ltd

8 Gangwal Healthcare

8 Actylis

6 Lonza Capsugel

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 DFE Pharma

4 Nanjing Well Pharmaceutical

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 ACG Worldwide

4 Kima Chemical

3 Vasa Pharmachem

3 DKSH

3 The Dow Chemical Company

3 Prachin Chemical

2 Jai Radhe Sales

2 Evonik

2 Qualicaps

2 Nomisma Healthcare

2 Seqens

1 Qianhao Chemical (Hebei) Co., Ltd

1 Alcedo Pharmachem

1 Clariant

1 Ingredion Pharma Solutions

1 Nanjing Bold Chemical

1 Pfanstiehl

1 Pharmatrans-Sanaq

1 Vertellus

1 SPI Pharma

1 Aeon Procare

1 Finar

EXCIPIENTS BY APPLICATIONS

60 Coating Systems & Additives

49 Fillers, Diluents & Binders

42 Controlled & Modified Release

22 Direct Compression

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons